Filtered By:
Source: Journal of Thrombosis and Thrombolysis
Condition: Thrombosis
Drug: Spironolactone
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial
ConclusionsThe present study shows that among ACS patients randomized in the REDUCE trial, a 3 months DAPT strategy offers comparable results as compared to a standard 12 months DAPT at 2-years follow-up in both male and female gender.
Source: Journal of Thrombosis and Thrombolysis - April 13, 2021 Category: Hematology Source Type: research
